Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eliem Therapeutics (ELYM)
NASDAQ:ELYM
RESEARCH TOOLSreports
Eliem Therapeutics (ELYM) Stock Price & Analysis
32 Followers
ELYM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.34 - $5.19
Previous Close$4.43
Volume208.90K
Average Volume (3M)717.43K
Market Cap
$122.80M
Enterprise Value$15.82M
Total Cash (Recent Filing)$107.43M
Total Debt (Recent Filing)$459.00K
Price to Earnings (P/E)-3.4
Beta-0.31
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.31
Shares Outstanding27,719,409
10 Day Avg. Volume4,191,047
30 Day Avg. Volume717,431
Standard Deviation0.18
R-Squared0.02
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)1.15
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)9.10
P/FCF Ratio9.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Eliem Therapeutics News
Ownership Overview
23.57% Insiders
1.53% Mutual Funds
59.92% Other Institutional Investors
14.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ELYM FAQ
What was Eliem Therapeutics’s price range in the past 12 months?
Eliem Therapeutics lowest stock price was $2.34 and its highest was $5.19 in the past 12 months.
What is Eliem Therapeutics’s market cap?
Currently, no data Available
When is Eliem Therapeutics’s upcoming earnings report date?
Eliem Therapeutics’s upcoming earnings report date is May 13, 2024 which is in 24 days.
How were Eliem Therapeutics’s earnings last quarter?
Eliem Therapeutics released its earnings results on Mar 04, 2024. The company reported -$0.131 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.131.
Is Eliem Therapeutics overvalued?
According to Wall Street analysts Eliem Therapeutics’s price is currently Overvalued.
Does Eliem Therapeutics pay dividends?
Eliem Therapeutics does not currently pay dividends.
What is Eliem Therapeutics’s EPS estimate?
Eliem Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eliem Therapeutics have?
Eliem Therapeutics has 27,719,410 shares outstanding.
What happened to Eliem Therapeutics’s price movement after its last earnings report?
Eliem Therapeutics reported an EPS of -$0.131 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.115%.
Which hedge fund is a major shareholder of Eliem Therapeutics?
Among the largest hedge funds holding Eliem Therapeutics’s share is RA Capital Management. It holds Eliem Therapeutics’s shares valued at 36M.
---
Eliem Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.15%
12-Months-Change
Fundamentals
Return on Equity
-29.72%
Trailing 12-Months
Asset Growth
-18.17%
Trailing 12-Months
Company Description
Eliem Therapeutics
Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.
---
ELYM Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ELYM
1 Year
1 Year Success Rate
1/13 ratings generated profit
1 Year Average Return
-42.93%
reiterated a buy rating 11 months ago
Copying Marc Goodman's trades and holding each position for 1 Year would result in 7.69% of your transactions generating a profit, with an average return of -42.93% per trade.
---